Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
27.22
-0.30 (-1.09%)
Nov 17, 2026, 3:00 PM CST
SHA:688076 Market Cap
SHA:688076 has a market cap or net worth of 8.62 billion as of November 16, 2026. It is the 8,480th most valuable company in the world and the 1,729th biggest in China. Its market cap has decreased by 32.16% in one year.
Market Cap
8.62B
Enterprise Value
10.28B
Revenue
2.16B
Global Rank
Country Rank
#1,729 China
PE Ratio
38.56
ChartMarket Cap Chart
Since May 20, 2021, SHA:688076's market cap has decreased from 16.52B to 8.62B, a decrease of -47.80%. That is a compound annual growth rate of -11.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 8.62B | -27.62% |
| Dec 31, 2025 | 11.92B | 4.42% |
| Dec 31, 2024 | 11.41B | 19.08% |
| Dec 29, 2023 | 9.58B | 95.95% |
| Dec 30, 2022 | 4.89B | -44.50% |
| Dec 31, 2021 | 8.81B | -46.67% |
| May 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 9.76B |
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Shanghai OPM Biosciences | 9.25B |
| Staidson (Beijing) BioPharmaceuticals | 8.93B |
| Hualan Biological Vaccine | 8.51B |
| Pacific Shuanglin Bio-pharmacy | 8.48B |
| Mabwell (Shanghai) Bioscience | 8.48B |
| Liaoning Chengda Biotechnology | 8.41B |